Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
20-23 May, 2025
Not Confirmed
Not Confirmed
21-23 May, 2025
Not Confirmed
Not Confirmed
21-23 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
20-23 May, 2025
Industry Trade Show
Not Confirmed
21-23 May, 2025
Industry Trade Show
Not Confirmed
21-23 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/us-drug-shortages-reduce-16-yoy-in-q1-2025-cns-drugs-antimicrobials-face-highest-scarcities
09 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/09/3078518/0/en/Entera-Bio-Announces-First-Quarter-2025-Financial-Results-and-Business-Updates.html
15 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/15/3061736/0/en/Entera-Bio-s-EB613-Demonstrates-Early-Impact-on-Both-Trabecular-and-Cortical-Bone-Compartments-with-6-Months-of-Treatment-in-Post-Menopausal-Women-with-Osteoporosis-Highlighted-as-.html
19 Mar 2025
// BIOSPACE
https://www.biospace.com/business/opko-and-entera-link-up-to-advance-first-oral-glp-1-glucagon-drug-into-clinic
08 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/08/2977864/0/en/Entera-Bio-Reports-Q3-2024-Financial-Results-and-Provides-Business-Updates.html
01 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/01/2922775/0/en/Entera-s-EB613-the-First-Once-Daily-PTH-1-34-Tablet-Treatment-Dedicated-to-Post-Menopausal-Women-with-High-Risk-Osteoporosis-Abstract-Selected-for-Presentation-at-the-ASBMR-2024-An.html
03 Jun 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/06/03/2892199/0/en/Entera-Bio-Reports-Phase-1-Clinical-Data-of-First-in-Class-Oral-PTH-1-34-Peptide-Candidate-EB612-for-Patients-with-Hypoparathyroidism-at-ENDO-2024.html
ABOUT THIS PAGE